Thyro-tabs

   
Google
 
Web NewDrugInformation.com

Thyro-tabs


Drug - Thyro-tabs
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Levothyroxine Sodium
Multiple ingredients are in alphabetical order.

Strength - 0.137MG **See Current Cumulative Supplement 1.3
The potency of the active ingredient(s), Levothyroxine Sodium. May repeat for multiple part products.

Applicant - LLOYD
The firm name holding legal responsibility for Thyro-tabs. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 021116
The FDA assigned number to Thyro-tabs. Format is nnnnnn.

Product Number - 012
The FDA assigned number to identify Thyro-tabs. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - BX
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Dec 7, 2004
The date Thyro-tabs was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Thyro-tabs. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Thyro-tabs is in. Format is RX, OTC, DISCN.

Applicant Full Name - Lloyd Inc
The full name of the firm holding legal responsibility for the new application of Thyro-tabs.

Thyro-tabs